Tirzepatide (Mounjaro) is a dual agonist that activates both GIP and GLP-1 receptors, leading to even greater weight loss than GLP-1 only drugs
Side effects include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and stomach pain
Previous physiological studies have shown that both GIP (113116) and GLP-1 (117) act in concert with glucose to enhance insulin gene transcription, mRNA stability, insulin biosynthesis, and insulin secretion
Focus on soft proteins (Greek yogurt, eggs, cottage cheese, shredded chicken), gentle carbs (rice, oats, toast, potatoes), cooked vegetables, and small portions you can actually finish
Algunos especialistas mencionan que estas situaciones pueden provocar inseguridad o cuestionamientos dentro del vnculo
Throughout the day, make a conscious effort to maintain correct posture